These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28972975)

  • 1. Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics.
    Stuart RM; Kerr CC; Haghparast-Bidgoli H; Estill J; Grobicki L; Baranczuk Z; Prieto L; Montañez V; Reporter I; Gray RT; Skordis-Worrall J; Keiser O; Cheikh N; Boonto K; Osornprasop S; Lavadenz F; Benedikt CJ; Martin-Hughes R; Hussain SA; Kelly SL; Kedziora DJ; Wilson DP
    PLoS One; 2017; 12(10):e0185077. PubMed ID: 28972975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case.
    Meyer-Rath G; van Rensburg C; Larson B; Jamieson L; Rosen S
    PLoS One; 2017; 12(10):e0186496. PubMed ID: 29073167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.
    Stuart RM; Grobicki L; Haghparast-Bidgoli H; Panovska-Griffiths J; Skordis J; Keiser O; Estill J; Baranczuk Z; Kelly SL; Reporter I; Kedziora DJ; Shattock AJ; Petravic J; Hussain SA; Grantham KL; Gray RT; Yap XF; Martin-Hughes R; Benedikt CJ; Fraser-Hurt N; Masaki E; Wilson DJ; Gorgens M; Mziray E; Cheikh N; Shubber Z; Kerr CC; Wilson DP
    J Int AIDS Soc; 2018 Apr; 21(4):e25097. PubMed ID: 29652100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization.
    Kerr CC; Stuart RM; Gray RT; Shattock AJ; Fraser-Hurt N; Benedikt C; Haacker M; Berdnikov M; Mahmood AM; Jaber SA; Gorgens M; Wilson DP
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):365-76. PubMed ID: 25803164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the 'no-one worse off' criterion to design Pareto efficient HIV responses in Sudan and Togo.
    Stuart RM; Haghparast-Bidgoli H; Panovska-Griffiths J; Grobicki L; Skordis J; Kerr CC; Kedziora DJ; Martin-Hughes R; Kelly SL; Wilson DP
    AIDS; 2019 Jun; 33(7):1247-1252. PubMed ID: 30664007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV prevention where it is needed most: comparison of strategies for the geographical allocation of interventions.
    Anderson SJ; Ghys PD; Ombam R; Hallett TB
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29220115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations.
    Shattock AJ; Kerr CC; Stuart RM; Masaki E; Fraser N; Benedikt C; Gorgens M; Wilson DP; Gray RT
    J Int AIDS Soc; 2016; 19(1):20627. PubMed ID: 26928810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV partner services in Kenya: a cost and budget impact analysis study.
    Cherutich P; Farquhar C; Wamuti B; Otieno FA; Ng'ang'a A; Mutiti PM; Macharia P; Sambai B; Bukusi D; Levin C;
    BMC Health Serv Res; 2018 Sep; 18(1):721. PubMed ID: 30223833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aligning budget with U.S. National HIV prevention priorities.
    Valdiserri RO; Ogden LO; Janssen RS; Onorato I; Martin T
    J Public Health Manag Pract; 2004; 10(2):140-7. PubMed ID: 14967981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
    McGillen JB; Anderson SJ; Hallett TB
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria.
    Gomez GB; Foster N; Brals D; Nelissen HE; Bolarinwa OA; Hendriks ME; Boers AC; van Eck D; Rosendaal N; Adenusi P; Agbede K; Akande TM; Boele van Hensbroek M; Wit FW; Hankins CA; Schultsz C
    PLoS One; 2015; 10(9):e0139048. PubMed ID: 26413788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting priorities for safe motherhood interventions in resource-scarce settings.
    Prata N; Sreenivas A; Greig F; Walsh J; Potts M
    Health Policy; 2010 Jan; 94(1):1-13. PubMed ID: 19773090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivering pediatric HIV care in resource-limited settings: cost considerations in an expanded response.
    Tolle MA; Phelps BR; Desmond C; Sugandhi N; Omeogu C; Jamieson D; Ahmed S; Reuben E; Muhe L; Kellerman SE;
    AIDS; 2013 Nov; 27 Suppl 2():S179-86. PubMed ID: 24361627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing efficiency and costs of scaling up HIV treatment.
    Cleary SM; McIntyre D; Boulle AM
    AIDS; 2008 Jul; 22 Suppl 1():S35-42. PubMed ID: 18664951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sharing the costs of structural interventions: What can models tell us?
    Stuart RM; Wilson DP
    Int J Drug Policy; 2021 Feb; 88():102702. PubMed ID: 32173275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS.
    Kelly SL; Martin-Hughes R; Stuart RM; Yap XF; Kedziora DJ; Grantham KL; Hussain SA; Reporter I; Shattock AJ; Grobicki L; Haghparast-Bidgoli H; Skordis-Worrall J; Baranczuk Z; Keiser O; Estill J; Petravic J; Gray RT; Benedikt CJ; Fraser N; Gorgens M; Wilson D; Kerr CC; Wilson DP
    Lancet HIV; 2018 Apr; 5(4):e190-e198. PubMed ID: 29540265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
    Chiu C; Johnson LF; Jamieson L; Larson BA; Meyer-Rath G
    BMC Public Health; 2017 Jan; 17(1):143. PubMed ID: 28143525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study.
    Zhang L; Phanuphak N; Henderson K; Nonenoy S; Srikaew S; Shattock AJ; Kerr CC; Omune B; van Griensven F; Osornprasop S; Oelrichs R; Ananworanich J; Wilson DP
    Lancet HIV; 2015 May; 2(5):e200-7. PubMed ID: 26423002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis.
    Haacker M; Fraser-Hurt N; Gorgens M
    PLoS Med; 2016 May; 13(5):e1002012. PubMed ID: 27138961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.